VVP
DMTK

Venture Visionary Partners’s DermTech, Inc. Common Stock DMTK Stock Holding History

Venture Visionary Partners’s Portfolio DMTK Stock Details DMTK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-100
Closed -$554 – 1625
2022
Q2 		$554 Buy
+100
New +$819 ﹤0.01% 1639

Other funds holding DMTK

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
UOC
UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
AAMU
AEGON Asset Management (UK) Edinburgh, United Kingdom $9.38B AUM 48.94% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AIA
Avalon Investment & Advisory Houston, Texas $3.65B AUM 0.47% 1-Year Est. Return
LCM
Landscape Capital Management Englewood, New Jersey $1.58B AUM 26.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Venture Visionary Partners's DMTK Position: Q3 2022 in Review

Venture Visionary Partners sold out of DermTech, Inc. Common Stock (DMTK) in Q3 2022, closing a stake of 100 shares — an estimated $554 sold.

Venture Visionary Partners first reported a position in DMTK in Q2 2022 and held it in 1 quarter. The position peaked at $554 in Q2 2022. 127 funds tracked by Wall St. Rank hold DMTK as of Q3 2022.

  • Venture Visionary Partners reported no remaining DermTech, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
  • Venture Visionary Partners sold 100 DermTech, Inc. Common Stock shares in Q3 2022, an estimated $554.
  • Venture Visionary Partners first reported a position in DermTech, Inc. Common Stock in Q2 2022 and held it in 1 quarter.
  • Venture Visionary Partners's DermTech, Inc. Common Stock position peaked at $554 in Q2 2022.
  • 127 funds tracked by Wall St. Rank held DermTech, Inc. Common Stock as of Q3 2022.

Based on Venture Visionary Partners's 13F filing for Q3 2022, filed 14 Nov 2022.